Hormonal contraception and risk of bacterial vaginosis diagnosis in an observational study of women attending STD clinics in Baltimore, MD
Abstract Background The protective effect of hormonal contraception may offer a potential intervention against bacterial vaginosis (BV). Study Design Three hundred thirty reproductive-age women enrolled in a contraceptive program from April 2005 to October 2006 at two sexually transmitted diseases c...
Gespeichert in:
| Veröffentlicht in: | Contraception (Stoneham) 2009-07, Vol.80 (1), p.63-67 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 67 |
|---|---|
| container_issue | 1 |
| container_start_page | 63 |
| container_title | Contraception (Stoneham) |
| container_volume | 80 |
| creator | Rifkin, Samara B Smith, Marsha R Brotman, Rebecca M Gindi, Renee M Erbelding, Emily J |
| description | Abstract Background The protective effect of hormonal contraception may offer a potential intervention against bacterial vaginosis (BV). Study Design Three hundred thirty reproductive-age women enrolled in a contraceptive program from April 2005 to October 2006 at two sexually transmitted diseases clinics in Baltimore, MD. Participants were supplied with hormonal contraceptives of their choice and followed prospectively. BV was diagnosed by Amsel's criteria. Results from population-level analysis were compared to a case-crossover analysis. Results BV was diagnosed in 189 (13.0%) of the visits among 133 (40.3%) women. In the population-level analysis, the use of progestin-only and combined contraception was associated with a decreased risk of BV compared to intervals of no hormonal contraceptive use [adjusted odds ratio (AOR): 0.42 (95% CI: 0.20–0.88) and AOR: 0.66 (95% CI: 0.39–1.10), respectively]. The case-crossover analysis demonstrated a similar trend in findings. Conclusion Hormonal contraception was associated with a decreased risk of BV in an STD clinic cohort. |
| doi_str_mv | 10.1016/j.contraception.2009.01.008 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67326061</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0010782409000250</els_id><sourcerecordid>20749950</sourcerecordid><originalsourceid>FETCH-LOGICAL-c497t-3b2215e060d195a2931c878a175e1949ca1487857a2342ba6fa732d80a631eb33</originalsourceid><addsrcrecordid>eNqNkt1u1DAQhSMEokvhFVAkBFckzDg_ToSEBG2hSEVctFxbE2d25W1ib-3son0FnhqHXYHKDVzZlr8zY58zSfICIUfA-s06185OnjRvJuNsLgDaHDAHaB4kC2xkm0GFzcNkAYCQyUaUJ8mTENYAINtKPk5OsK0ABcpF8uPS-dFZGtJ7RVOyfepNuE3dMu1IT-xNZHa0MtYFE9Le0OqwMzOcui6w39GsjVyYtv1-ln53I8f7aWLbG7tKr2_OUz0Ya_Qv4QcaJjM6z6_TL-dPk0dLGgI_O66nybePFzdnl9nV10-fz95fZbps5ZQVnRBYMdTQx2-QaAvUjWwIZcXYlq0mLOO5kiSKUnRUL0kWom-A6gK5K4rT5NWh7sa7uy2HSY0maB4Gsuy2QdURr6HGf4ICZNlGJyP49gBq70LwvFQbb0bye4Wg5szUWt2zV82ZKUAVM4vq58c2227k_o_2GFIEXh4BCpqGpSerTfjNCaxLgUUVuYsDx9G9nWGvgjZsNffGs55U78x_PujdX3UOkdFwy3sOa7f1MeSgUAWhQF3PYzZPGbRxwkT04yd9UNKf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20749950</pqid></control><display><type>article</type><title>Hormonal contraception and risk of bacterial vaginosis diagnosis in an observational study of women attending STD clinics in Baltimore, MD</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Rifkin, Samara B ; Smith, Marsha R ; Brotman, Rebecca M ; Gindi, Renee M ; Erbelding, Emily J</creator><creatorcontrib>Rifkin, Samara B ; Smith, Marsha R ; Brotman, Rebecca M ; Gindi, Renee M ; Erbelding, Emily J</creatorcontrib><description>Abstract Background The protective effect of hormonal contraception may offer a potential intervention against bacterial vaginosis (BV). Study Design Three hundred thirty reproductive-age women enrolled in a contraceptive program from April 2005 to October 2006 at two sexually transmitted diseases clinics in Baltimore, MD. Participants were supplied with hormonal contraceptives of their choice and followed prospectively. BV was diagnosed by Amsel's criteria. Results from population-level analysis were compared to a case-crossover analysis. Results BV was diagnosed in 189 (13.0%) of the visits among 133 (40.3%) women. In the population-level analysis, the use of progestin-only and combined contraception was associated with a decreased risk of BV compared to intervals of no hormonal contraceptive use [adjusted odds ratio (AOR): 0.42 (95% CI: 0.20–0.88) and AOR: 0.66 (95% CI: 0.39–1.10), respectively]. The case-crossover analysis demonstrated a similar trend in findings. Conclusion Hormonal contraception was associated with a decreased risk of BV in an STD clinic cohort.</description><identifier>ISSN: 0010-7824</identifier><identifier>EISSN: 1879-0518</identifier><identifier>DOI: 10.1016/j.contraception.2009.01.008</identifier><identifier>PMID: 19501217</identifier><identifier>CODEN: CCPTAY</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Ambulatory Care Facilities ; Bacteria ; Bacterial diseases ; Bacterial diseases of the genital system ; Bacterial vaginosis ; Baltimore ; Biological and medical sciences ; Case-crossover analysis ; Combined hormonal contraception ; Contraceptives, Oral, Combined - therapeutic use ; Depot medroxyprogesterone acetate (DMPA) ; Female ; Generalized estimating equations (GEE) ; Genital system. Reproduction ; Human bacterial diseases ; Humans ; Infectious diseases ; Medical sciences ; Obstetrics and Gynecology ; Pharmacology. Drug treatments ; Progestin-only contraception ; Progestins - therapeutic use ; Prospective Studies ; Risk Assessment ; Vaginosis, Bacterial - diagnosis ; Vaginosis, Bacterial - prevention & control ; Young Adult</subject><ispartof>Contraception (Stoneham), 2009-07, Vol.80 (1), p.63-67</ispartof><rights>Elsevier Inc.</rights><rights>2009 Elsevier Inc.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c497t-3b2215e060d195a2931c878a175e1949ca1487857a2342ba6fa732d80a631eb33</citedby><cites>FETCH-LOGICAL-c497t-3b2215e060d195a2931c878a175e1949ca1487857a2342ba6fa732d80a631eb33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.contraception.2009.01.008$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21642135$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19501217$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rifkin, Samara B</creatorcontrib><creatorcontrib>Smith, Marsha R</creatorcontrib><creatorcontrib>Brotman, Rebecca M</creatorcontrib><creatorcontrib>Gindi, Renee M</creatorcontrib><creatorcontrib>Erbelding, Emily J</creatorcontrib><title>Hormonal contraception and risk of bacterial vaginosis diagnosis in an observational study of women attending STD clinics in Baltimore, MD</title><title>Contraception (Stoneham)</title><addtitle>Contraception</addtitle><description>Abstract Background The protective effect of hormonal contraception may offer a potential intervention against bacterial vaginosis (BV). Study Design Three hundred thirty reproductive-age women enrolled in a contraceptive program from April 2005 to October 2006 at two sexually transmitted diseases clinics in Baltimore, MD. Participants were supplied with hormonal contraceptives of their choice and followed prospectively. BV was diagnosed by Amsel's criteria. Results from population-level analysis were compared to a case-crossover analysis. Results BV was diagnosed in 189 (13.0%) of the visits among 133 (40.3%) women. In the population-level analysis, the use of progestin-only and combined contraception was associated with a decreased risk of BV compared to intervals of no hormonal contraceptive use [adjusted odds ratio (AOR): 0.42 (95% CI: 0.20–0.88) and AOR: 0.66 (95% CI: 0.39–1.10), respectively]. The case-crossover analysis demonstrated a similar trend in findings. Conclusion Hormonal contraception was associated with a decreased risk of BV in an STD clinic cohort.</description><subject>Adult</subject><subject>Ambulatory Care Facilities</subject><subject>Bacteria</subject><subject>Bacterial diseases</subject><subject>Bacterial diseases of the genital system</subject><subject>Bacterial vaginosis</subject><subject>Baltimore</subject><subject>Biological and medical sciences</subject><subject>Case-crossover analysis</subject><subject>Combined hormonal contraception</subject><subject>Contraceptives, Oral, Combined - therapeutic use</subject><subject>Depot medroxyprogesterone acetate (DMPA)</subject><subject>Female</subject><subject>Generalized estimating equations (GEE)</subject><subject>Genital system. Reproduction</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Obstetrics and Gynecology</subject><subject>Pharmacology. Drug treatments</subject><subject>Progestin-only contraception</subject><subject>Progestins - therapeutic use</subject><subject>Prospective Studies</subject><subject>Risk Assessment</subject><subject>Vaginosis, Bacterial - diagnosis</subject><subject>Vaginosis, Bacterial - prevention & control</subject><subject>Young Adult</subject><issn>0010-7824</issn><issn>1879-0518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkt1u1DAQhSMEokvhFVAkBFckzDg_ToSEBG2hSEVctFxbE2d25W1ib-3son0FnhqHXYHKDVzZlr8zY58zSfICIUfA-s06185OnjRvJuNsLgDaHDAHaB4kC2xkm0GFzcNkAYCQyUaUJ8mTENYAINtKPk5OsK0ABcpF8uPS-dFZGtJ7RVOyfepNuE3dMu1IT-xNZHa0MtYFE9Le0OqwMzOcui6w39GsjVyYtv1-ln53I8f7aWLbG7tKr2_OUz0Ya_Qv4QcaJjM6z6_TL-dPk0dLGgI_O66nybePFzdnl9nV10-fz95fZbps5ZQVnRBYMdTQx2-QaAvUjWwIZcXYlq0mLOO5kiSKUnRUL0kWom-A6gK5K4rT5NWh7sa7uy2HSY0maB4Gsuy2QdURr6HGf4ICZNlGJyP49gBq70LwvFQbb0bye4Wg5szUWt2zV82ZKUAVM4vq58c2227k_o_2GFIEXh4BCpqGpSerTfjNCaxLgUUVuYsDx9G9nWGvgjZsNffGs55U78x_PujdX3UOkdFwy3sOa7f1MeSgUAWhQF3PYzZPGbRxwkT04yd9UNKf</recordid><startdate>20090701</startdate><enddate>20090701</enddate><creator>Rifkin, Samara B</creator><creator>Smith, Marsha R</creator><creator>Brotman, Rebecca M</creator><creator>Gindi, Renee M</creator><creator>Erbelding, Emily J</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>7U1</scope><scope>7U2</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20090701</creationdate><title>Hormonal contraception and risk of bacterial vaginosis diagnosis in an observational study of women attending STD clinics in Baltimore, MD</title><author>Rifkin, Samara B ; Smith, Marsha R ; Brotman, Rebecca M ; Gindi, Renee M ; Erbelding, Emily J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c497t-3b2215e060d195a2931c878a175e1949ca1487857a2342ba6fa732d80a631eb33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Ambulatory Care Facilities</topic><topic>Bacteria</topic><topic>Bacterial diseases</topic><topic>Bacterial diseases of the genital system</topic><topic>Bacterial vaginosis</topic><topic>Baltimore</topic><topic>Biological and medical sciences</topic><topic>Case-crossover analysis</topic><topic>Combined hormonal contraception</topic><topic>Contraceptives, Oral, Combined - therapeutic use</topic><topic>Depot medroxyprogesterone acetate (DMPA)</topic><topic>Female</topic><topic>Generalized estimating equations (GEE)</topic><topic>Genital system. Reproduction</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Obstetrics and Gynecology</topic><topic>Pharmacology. Drug treatments</topic><topic>Progestin-only contraception</topic><topic>Progestins - therapeutic use</topic><topic>Prospective Studies</topic><topic>Risk Assessment</topic><topic>Vaginosis, Bacterial - diagnosis</topic><topic>Vaginosis, Bacterial - prevention & control</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rifkin, Samara B</creatorcontrib><creatorcontrib>Smith, Marsha R</creatorcontrib><creatorcontrib>Brotman, Rebecca M</creatorcontrib><creatorcontrib>Gindi, Renee M</creatorcontrib><creatorcontrib>Erbelding, Emily J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Contraception (Stoneham)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rifkin, Samara B</au><au>Smith, Marsha R</au><au>Brotman, Rebecca M</au><au>Gindi, Renee M</au><au>Erbelding, Emily J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hormonal contraception and risk of bacterial vaginosis diagnosis in an observational study of women attending STD clinics in Baltimore, MD</atitle><jtitle>Contraception (Stoneham)</jtitle><addtitle>Contraception</addtitle><date>2009-07-01</date><risdate>2009</risdate><volume>80</volume><issue>1</issue><spage>63</spage><epage>67</epage><pages>63-67</pages><issn>0010-7824</issn><eissn>1879-0518</eissn><coden>CCPTAY</coden><abstract>Abstract Background The protective effect of hormonal contraception may offer a potential intervention against bacterial vaginosis (BV). Study Design Three hundred thirty reproductive-age women enrolled in a contraceptive program from April 2005 to October 2006 at two sexually transmitted diseases clinics in Baltimore, MD. Participants were supplied with hormonal contraceptives of their choice and followed prospectively. BV was diagnosed by Amsel's criteria. Results from population-level analysis were compared to a case-crossover analysis. Results BV was diagnosed in 189 (13.0%) of the visits among 133 (40.3%) women. In the population-level analysis, the use of progestin-only and combined contraception was associated with a decreased risk of BV compared to intervals of no hormonal contraceptive use [adjusted odds ratio (AOR): 0.42 (95% CI: 0.20–0.88) and AOR: 0.66 (95% CI: 0.39–1.10), respectively]. The case-crossover analysis demonstrated a similar trend in findings. Conclusion Hormonal contraception was associated with a decreased risk of BV in an STD clinic cohort.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>19501217</pmid><doi>10.1016/j.contraception.2009.01.008</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0010-7824 |
| ispartof | Contraception (Stoneham), 2009-07, Vol.80 (1), p.63-67 |
| issn | 0010-7824 1879-0518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67326061 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Adult Ambulatory Care Facilities Bacteria Bacterial diseases Bacterial diseases of the genital system Bacterial vaginosis Baltimore Biological and medical sciences Case-crossover analysis Combined hormonal contraception Contraceptives, Oral, Combined - therapeutic use Depot medroxyprogesterone acetate (DMPA) Female Generalized estimating equations (GEE) Genital system. Reproduction Human bacterial diseases Humans Infectious diseases Medical sciences Obstetrics and Gynecology Pharmacology. Drug treatments Progestin-only contraception Progestins - therapeutic use Prospective Studies Risk Assessment Vaginosis, Bacterial - diagnosis Vaginosis, Bacterial - prevention & control Young Adult |
| title | Hormonal contraception and risk of bacterial vaginosis diagnosis in an observational study of women attending STD clinics in Baltimore, MD |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T11%3A51%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hormonal%20contraception%20and%20risk%20of%20bacterial%20vaginosis%20diagnosis%20in%20an%20observational%20study%20of%20women%20attending%20STD%20clinics%20in%20Baltimore,%20MD&rft.jtitle=Contraception%20(Stoneham)&rft.au=Rifkin,%20Samara%20B&rft.date=2009-07-01&rft.volume=80&rft.issue=1&rft.spage=63&rft.epage=67&rft.pages=63-67&rft.issn=0010-7824&rft.eissn=1879-0518&rft.coden=CCPTAY&rft_id=info:doi/10.1016/j.contraception.2009.01.008&rft_dat=%3Cproquest_cross%3E20749950%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20749950&rft_id=info:pmid/19501217&rft_els_id=S0010782409000250&rfr_iscdi=true |